Compare PLCE & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLCE | BHST |
|---|---|---|
| Founded | 1969 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.6M | 162.2M |
| IPO Year | 1997 | N/A |
| Metric | PLCE | BHST |
|---|---|---|
| Price | $7.56 | $6.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $8.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 543.6K | 110.6K |
| Earning Date | 11-20-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,338,867,000.00 | $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | $0.68 | $55.91 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 45.88 |
| 52 Week Low | $3.66 | $4.72 |
| 52 Week High | $16.78 | $12.80 |
| Indicator | PLCE | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 47.08 | 39.08 |
| Support Level | $6.86 | $5.80 |
| Resistance Level | $9.10 | $7.20 |
| Average True Range (ATR) | 0.66 | 0.94 |
| MACD | -0.07 | 0.07 |
| Stochastic Oscillator | 23.84 | 24.80 |
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.